share_log
Reuters ·  May 7 16:35
Immuneering Corp: Initial Data From Multiple Imm-1-104 Phase 2a Arms Expected in 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment